Company Filing History:
Years Active: 2010
Title: Michlaki Takahashi: Innovator in Gene Therapy
Introduction
Michlaki Takahashi is a distinguished inventor based in Suita, Japan, known for his contributions to the field of gene therapy. With a focus on recombinant technology, his innovative work has paved the way for new methods in gene transfer to lymphoid cells.
Latest Patents
Takahashi holds a notable patent for a "Recombinant viral vector for gene transfer into lymphoid cells." This invention encompasses a recombinant herpesvirus, a method for producing this recombinant herpesvirus, and a pharmaceutical composition that utilizes it. The patent details a process for generating a recombinant herpesvirus using a BAC vector sequence, along with a vector that includes a herpesvirus genomic gene, a BAC vector sequence, and relevant nucleic acid components capable of homologous recombination with a herpesvirus genome.
Career Highlights
Currently affiliated with Osaka University, Takahashi has distinguished himself as a key figure in his research institution. His work is instrumental in advancing the understanding and application of viral vectors for therapeutic purposes.
Collaborations
Throughout his career, Michlaki Takahashi has collaborated with notable colleagues, including Yasuko Mori and Kenjiro Tadagaki. These partnerships foster innovative research and contribute to the development of pioneering therapies in the field.
Conclusion
Michlaki Takahashi's innovative work and his singular patent illustrate his commitment to advancing gene therapy. His contributions at Osaka University and his collaborations with esteemed colleagues reflect the impact of his research on the scientific community and the potential for future advancements in medical technology.